MCM
ASMB icon

Monimus Capital Management’s Assembly Biosciences ASMB Stock Holding History

Monimus Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
48,390
+10,089
+26% +$288K 0.37% 50
2025
Q4 		$1.3M Sell
38,301
-3,766
-9% -$121K 0.86% 39
2025
Q3 		$1.08M Hold
42,067
– – 0.66% 42
2025
Q2 		$762K Hold
42,067
– – 0.55% 46
2025
Q1 		$402K Hold
42,067
– – 0.34% 42
2024
Q4 		$664K Buy
+42,067
New +$677K 0.63% 41

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Monimus Capital Management's ASMB Position: Q1 2026 in Review

Monimus Capital Management increased its Assembly Biosciences (ASMB) stake by 26% in Q1 2026, buying an estimated $288K and bringing the position to 48,390 shares worth $1.34M. The position accounts for 0.37% of the portfolio, ranked #50.

Monimus Capital Management first reported a position in ASMB in Q4 2024 and has held it in 6 quarters since. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Monimus Capital Management held 48,390 shares of Assembly Biosciences worth $1.34M as of Q1 2026.
  • Monimus Capital Management bought 10,089 Assembly Biosciences shares in Q1 2026, an estimated $288K.
  • Assembly Biosciences made up 0.37% of Monimus Capital Management's portfolio in Q1 2026, its #50 holding.
  • Monimus Capital Management first reported a position in Assembly Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Monimus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.